[{"id":"4cd4d549-9fc1-46f8-8fc0-b58e00e888d6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05499715","created_at":"2022-11-08T19:21:33.288Z","updated_at":"2024-07-02T16:36:05.605Z","phase":"Phase 1","brief_title":"A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors","source_id_and_acronym":"NCT05499715","lead_sponsor":"Chinese Academy of Medical Sciences","biomarkers":" PD-1","pipe":" | ","alterations":" PD-1 positive","tags":["PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-1 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ScTIL"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 09/30/2022","start_date":" 09/30/2022","primary_txt":" Primary completion: 05/30/2024","primary_completion_date":" 05/30/2024","study_txt":" Completion: 08/30/2024","study_completion_date":" 08/30/2024","last_update_posted":"2022-08-12"}]